accacc2022acc2023acc2024acuteaddressingadherenceadjuvantadultsadvancedanalysisartarterialasco2021ashash2021ash2023ash2024asthmaatrialbasedbccbenefitsbetabetterbloodbreakingbreastcancercarcinomacardiologycardiovascularcarecellcervicalchallengeschemotherapychest2024cholesterolchronicclinicalcllcombinationcontroversiescopdcoronarycovidcurrentcvdatadiabetesdiagnosisdiseasediseasesdoseearlyeaseas2022easd2022effectefficacyehaehra2022ers2024escesc2021esc2022esc2023esc2024eshesh2022esh2023esh2024esmoesmo2021esmo2023esmo2024eular2024eventsevidenceevolutionfactorsfailurefibrillationfirstfocusedfuturegallenglpguidanceguidelineshearther2hfpefhighhighlightshrhypertensionhypertensiveimmuneimmunotherapyimproveimprovesinhibitorsinterviewish2021isth2022jointkeynotekidneylargelateleukemialifelipoproteinliraglutidelonglowloweringlunglymphomamanagementmanagingmelanomametametastaticmultiplemyelofibrosismyeloidmyelomanavigatingnovelnoveltiesobesityolderoptionsoutcomesoverallpacingpatientpatientspembrolizumabpeoplephasepluspositivepostpracticepressurepreventionprogressionprostatepulmonaryquestionsrandomizedrccrealreceptorrecurrencereducedreducesreductionrenalresponseresultsriskrolesabcs2021sabcs2024screeningsemaglutidesessionsglt2showsststandardstatestrategiesstudysurgerysurvivalsymposiumsyndromestargetedtermtherapeutictherapiestherapytreatmenttrialtrialstripleupdateupdatesvaccinationvaccineversusvteworldwvcdc